icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow 2022
23-26 October
Virtual Meeting
Back grey_arrow_rt.gif
 
 
 
2-Year Outcomes of Dolutegravir (DTG) and Lamivudine (3TC) in Art-Naive and Pre-treated People Living With HIV in Germany: Real-world Data From the German URBAN Cohort
 
 
  Glasgow 2022 Oct 23-26
 
Daniel Beer,1 Jenny Scherzer,2 Sebastian Noe,3 Stefan Scholten,4 Christoph Wyen,5 Nils Postel,6 Olaf Degen,7 Michael Sabranski,8 Bernd Westermayer,9 Kathrin M. Dymek2 1PZB Aachen - Praxis Dr. H. Knechten, Aachen, Germany; 2ViiV Healthcare, Munich, Germany; 3MVZ München am Goetheplatz, Munich, Germany; 4Praxis Hohenstaufenring, Cologne, Germany; 5Praxis Ebertplatz, Cologne, Germany; 6prinzmed, Munich, Germany; 7Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 8Infektionsmedizinisches Zentrum Hamburg (ICH), Hamburg, Germany; 9GSK, Munich, Germany

1028221

1028222

1028223

1028224

1028225

Acknowledge